Literature DB >> 6691638

Hodgkin's disease in patients over sixty years old.

M M Austin-Seymour, R T Hoppe, R S Cox, S A Rosenberg, H S Kaplan.   

Abstract

Fifty-two patients 60 to 75 years of age were treated for Hodgkin's disease at Stanford University between 1968 and 1980. Adequate staging was defined as including a lymphogram and staging laparotomy for stage I to III and a positive bone marrow or liver biopsy or other evidence of diffuse involvement of extralymphatic tissues for stage IV. Adequate treatment was defined as subtotal lymphoid irradiation for pathologic stages I to IIA; total lymphoid irradiation for stages IIB to IIIA; and chemotherapy with or without irradiation for stages IIIB to IV. Twenty-four patients (46%) had advanced disease (IIIB to IV). Those patients who received appropriate treatment had a median survival of only 39 months. Of the 28 patients with limited disease (I to IIIA), 15 had laparotomy and adequate treatment. Thirteen did not have a laparotomy and 7 were treated with involved-field irradiation. The 5-year survival rate in the laparotomy-staged and adequately treated group was 86%, but in the clinically staged group, only 35% (p = 0.006).

Entities:  

Mesh:

Year:  1984        PMID: 6691638     DOI: 10.7326/0003-4819-100-1-13

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  4 in total

Review 1.  Clinical aspects of Hodgkin's disease.

Authors:  G M Mead; J M Whitehouse
Journal:  BMJ       Date:  1988-12-17

Review 2.  The unique characteristics and management of patients over 60 years of age with classic Hodgkin lymphoma.

Authors:  Teresa V Halbsguth; Boris Böll; Peter Borchmann; Volker Diehl
Journal:  Curr Hematol Malig Rep       Date:  2011-09       Impact factor: 3.952

3.  ABVD as the treatment option in advanced Hodgkin's lymphoma patients older than 45 years.

Authors:  Bosko M Andjelic; Biljana S Mihaljevic; Ljubomir R Jakovic
Journal:  Pathol Oncol Res       Date:  2012-01-11       Impact factor: 3.201

Review 4.  Problems in the use of anticancer drugs in the elderly.

Authors:  J E Phister; S G Jue; B J Cusack
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.